Sensei Biotherapeutics Inc (SNSE) Stock
SNSE is no longer traded. Sensei Biotherapeutics was delisted from the Nasdaq in July 2026.
Prices on this page are historical; the last trade was July 17, 2026 at $25.96.
Sensei Biotherapeutics stock price history
SNSE final trading statistics
- Final close
- $25.96
- Final trading day
- Jul 17, 2026
- Market cap at delisting
- $34.84M
- Shares outstanding
- 1.34M
- Final 52-week range
- $6.33 – $36.93
- Avg. volume (final 3 mo.)
- 65,417
- All-time high (split-adj.)
- $455.00 · Feb 2021
- All-time low (split-adj.)
- $5.78 · Apr 2025
- Return since IPO
- -93.1%
- Beta
- -0.23
- Book value / share
- -$102.43
- Price / book
- -0.25
Sensei Biotherapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | -$21.1M | -$11.54 |
| FY2024 | $0.00 | -$30.2M | -$1.16 |
| FY2023 | $0.00 | -$34.1M | -$1.22 |
| FY2022 | $0.00 | -$48.8M | -$1.58 |
| FY2021 | $0.00 | -$36.8M | -$1.36 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Sensei Biotherapeutics stock FAQ
What happened to Sensei Biotherapeutics stock?
Sensei Biotherapeutics stock was delisted from the Nasdaq. Its final close was $25.96 on July 17, 2026.
Is SNSE stock still trading?
No. SNSE was delisted from the Nasdaq in July 2026 and no longer trades on a U.S. exchange.
What was the last price of SNSE stock?
SNSE closed at $25.96 on its final trading day, July 17, 2026, for a market value of about $34.84M.
What were Sensei Biotherapeutics's revenue and earnings in its last full fiscal year?
Sensei Biotherapeutics reported revenue of $0.00 and net income of -$21.1M in fiscal 2025, its last full year as a public company.
When did Sensei Biotherapeutics go public?
Sensei Biotherapeutics Inc stock began trading on February 4, 2021.